Cumberland Pharmaceuticals Inc
CPIXNasdaqCIK 1087294HealthcareFiscal year ends Dec 31
Reports and events: 324 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-09-0619:56 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001628280-23-031458 |
| 2023-08-1117:05 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001628280-23-029112 |
| 2023-08-0817:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-028289 |
| 2023-06-3017:20 ET | 8-K | 8.01 Other events | 0001628280-23-024065 |
| 2023-06-2217:31 ET | 8-K | 8.01 Other events | 0001628280-23-022935 |
| 2023-06-0717:01 ET | 8-K | 8.01 Other events | 0001628280-23-021318 |
| 2023-06-0217:18 ET | 8-K | 4.01 Change of auditor | 0001628280-23-020697 |
| 2023-05-2417:02 ET | 8-K | 4.01 Change of auditor | 0001628280-23-019604 |
| 2023-05-1617:08 ET | 8-K | 8.01 Other events | 0001628280-23-018467 |
| 2023-05-1217:02 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001628280-23-017951 |
| 2023-05-0917:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-016892 |
| 2023-04-2817:12 ET | 8-K | 5.07 Shareholder vote results | 0001628280-23-014265 |
| 2023-04-1717:41 ET | 8-K | 8.01 Other events | 0001628280-23-011672 |
| 2023-04-0408:34 ET | 8-K | 8.01 Other events | 0001628280-23-010469 |
| 2023-03-1507:40 ET | DEF 14A | Proxy statementPeriod 2023-03-15 | 0001628280-23-007954 |
| 2023-03-1507:39 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-23-007952 |
| 2023-03-1317:02 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001628280-23-007727 |
| 2023-03-0717:21 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-006782 |
| 2023-01-1717:08 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-23-001129 |
| 2022-12-1217:20 ET | 8-K | 8.01 Other events | 0001628280-22-031743 |
| 2022-11-1417:11 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001628280-22-029906 |
| 2022-11-0817:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-028987 |
| 2022-08-1217:12 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001628280-22-022735 |
| 2022-08-0917:06 ET | 8-K | 2.02 Results of operations | 0001628280-22-021989 |
| 2022-07-1917:03 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-22-019114 |
| 2022-06-0317:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-22-016201 |
| 2022-05-1317:06 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001628280-22-014372 |
| 2022-05-1017:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-013656 |
| 2022-05-0317:11 ET | 8-K | 5.07 Shareholder vote results | 0001628280-22-012039 |
| 2022-04-2510:00 ET | 8-K | 8.01 Other events | 0001628280-22-010078 |
| 2022-03-2217:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-22-006915 |
| 2022-03-1717:05 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001628280-22-006570 |
| 2022-03-1717:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-22-006568 |
| 2022-03-1617:09 ET | DEF 14A | Proxy statementPeriod 2022-04-28 | 0001628280-22-006406 |
| 2022-03-1117:12 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001628280-22-005942 |
| 2022-03-0817:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-005405 |
| 2022-01-0617:30 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-22-000440 |
| 2022-01-0308:58 ET | 8-K | 1.01 Entry into a material agreement | 0001628280-22-000008 |
| 2021-12-2717:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-21-025612 |
| 2021-12-0117:52 ET | 8-K | 8.01 Other events | 0001628280-21-024264 |
| 2021-11-1917:17 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-21-023902 |
| 2021-11-1217:16 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001628280-21-023213 |
| 2021-11-0917:23 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-21-022599 |
| 2021-11-0117:25 ET | 8-K | 1.01 Entry into a material agreement | 0001628280-21-021025 |
| 2021-08-1317:08 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001628280-21-017022 |
| 2021-08-1017:15 ET | 8-K | 2.02 Results of operations | 0001628280-21-016443 |
| 2021-06-1417:15 ET | 8-K | 1.01 Entry into a material agreement | 0001628280-21-012190 |
| 2021-05-1417:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001628280-21-010388 |
| 2021-05-1417:14 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001628280-21-010387 |
| 2021-05-1117:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-21-009844 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:41 ET. Listed shows no prices and gives no investment advice.